Skip to main content
GutCited
Figure 8

Описание

Key bacterial taxa differentially abundant between treatment groups are identified, with specific genera associated with improved metabolic outcomes in the combination therapy arm.

More Figures from This Paper

The experimental design outlines the group allocation including sodium carboxymethyl cellulose control, berberine-evodiamine combination, and fenofibrate positive control arms.

Figure 5

The experimental design outlines the group allocation including sodium carboxymethyl cellulose control, berberine-evodiamine combination, and fenofibrate positive control arms.

flowchart
Gut microbiota composition analyzed by 16S rRNA sequencing reveals distinct community structures across treatment groups, with the combination therapy restoring microbial diversity.

Figure 6

Gut microbiota composition analyzed by 16S rRNA sequencing reveals distinct community structures across treatment groups, with the combination therapy restoring microbial diversity.

chart
Alpha diversity indices of gut microbiota are compared across groups, indicating that berberine and evodiamine co-administration partially reverses high-fat diet-induced dysbiosis.

Figure 7

Alpha diversity indices of gut microbiota are compared across groups, indicating that berberine and evodiamine co-administration partially reverses high-fat diet-induced dysbiosis.

chart
Short-chain fatty acid concentrations in fecal samples reflect changes in microbial metabolic activity following berberine and evodiamine treatment.

Figure 9

Short-chain fatty acid concentrations in fecal samples reflect changes in microbial metabolic activity following berberine and evodiamine treatment.

chart
Correlation analysis between gut microbiota composition and hepatic lipid parameters links specific bacterial taxa to the amelioration of non-alcoholic fatty liver disease.

Figure 10

Correlation analysis between gut microbiota composition and hepatic lipid parameters links specific bacterial taxa to the amelioration of non-alcoholic fatty liver disease.

chart

Figure 8

Chart
776 × 1133px · 481,3 КБ

Source Paper

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in …

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas (2022)

PMID: 35584453

DOI: 10.1590/1414-431X2022e12096

Cite This Figure

![Figure 8: Key bacterial taxa differentially abundant between treatment groups are identified, with specific genera associated with improved metabolic outcomes in the combination therapy arm.](https://pdfs.citedhealth.com/figures/35584453/153.png)

> Source: Yufan Dai et al. "The combination of berberine and evodiamine ameliorates high-fat diet-induced no." *Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas*, 2022. PMID: [35584453](https://pubmed.ncbi.nlm.nih.gov/35584453/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/35584453/153.png" alt="Key bacterial taxa differentially abundant between treatment groups are identified, with specific genera associated with improved metabolic outcomes in the combination therapy arm." />
  <figcaption>Figure 8. Key bacterial taxa differentially abundant between treatment groups are identified, with specific genera associated with improved metabolic outcomes in the combination therapy arm.<br>  Source: Yufan Dai et al. "The combination of berberine and evodiamine ameliorates high-fat diet-induced no." <em>Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35584453/">35584453</a></figcaption>
</figure>

Связанные доказательства

D
Berberine для Gut Dysbiosis

Оценка D · 2 исследований